471 related articles for article (PubMed ID: 25347806)
21. Prospects for controlling future pandemics of influenza.
Robertson JS; Inglis SC
Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
[TBL] [Abstract][Full Text] [Related]
22. Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour.
Vilches TN; Jaberi-Douraki M; Moghadas SM
Epidemiol Infect; 2019 Jan; 147():e75. PubMed ID: 30869007
[TBL] [Abstract][Full Text] [Related]
23. Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017-2018 winter influenza season.
Ho SH; He D; Eftimie R
J Theor Biol; 2019 Sep; 476():74-94. PubMed ID: 31128142
[TBL] [Abstract][Full Text] [Related]
24. Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
Bolton KJ; McCaw JM; Brown L; Jackson D; Kedzierska K; McVernon J
PLoS One; 2015; 10(3):e0120138. PubMed ID: 25811654
[TBL] [Abstract][Full Text] [Related]
25. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
26. Anticipating crisis: towards a pandemic flu vaccination strategy through alignment of public health and industrial policy.
Daems R; Del Giudice G; Rappuoli R
Vaccine; 2005 Dec; 23(50):5732-42. PubMed ID: 16271423
[TBL] [Abstract][Full Text] [Related]
27. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
[TBL] [Abstract][Full Text] [Related]
28. Influenza vaccine efficacy trials: a simulation approach to understand failures from the past.
Benoit A; Legrand C; Dewé W
Pharm Stat; 2015; 14(4):294-301. PubMed ID: 25924929
[TBL] [Abstract][Full Text] [Related]
29. Mathematical model of transmission dynamics and optimal control strategies for 2009 A/H1N1 influenza in the Republic of Korea.
Kim S; Lee J; Jung E
J Theor Biol; 2017 Jan; 412():74-85. PubMed ID: 27769686
[TBL] [Abstract][Full Text] [Related]
30. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
31. An epidemic model with a multistage vaccine.
DeLegge A; Hunzinger K; Khatri R; Munir K
Bull Math Biol; 2015 Mar; 77(3):499-513. PubMed ID: 25698086
[TBL] [Abstract][Full Text] [Related]
32. Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
Degeling C; Williams J; Carter SM; Moss R; Massey P; Gilbert GL; Shih P; Braunack-Mayer A; Crooks K; Brown D; McVernon J
Vaccine; 2021 Jan; 39(2):255-262. PubMed ID: 33317870
[TBL] [Abstract][Full Text] [Related]
33. Impact of viral drift on vaccination dynamics and patterns of seasonal influenza.
Xiao Y; Moghadas SM
BMC Infect Dis; 2013 Dec; 13():589. PubMed ID: 24330575
[TBL] [Abstract][Full Text] [Related]
34. Influenza vaccination in immunocompromised patients: efficacy and safety.
Zbinden D; Manuel O
Immunotherapy; 2014; 6(2):131-9. PubMed ID: 24491087
[TBL] [Abstract][Full Text] [Related]
35. A note on the use of optimal control on a discrete time model of influenza dynamics.
González-Parra PA; Lee S; Velázquez L; Castillo-Chavez C
Math Biosci Eng; 2011 Jan; 8(1):183-97. PubMed ID: 21361407
[TBL] [Abstract][Full Text] [Related]
36. Influenza in Poland in 2011-2012 and in 2011/2012 and 2012/2013 epidemic seasons.
Czarkowski MP; Hallmann-Szelińska E; Staszewska E; Bednarska K; Kondratiuk K; Brydak LB
Przegl Epidemiol; 2014; 68(3):455-63, 559-65. PubMed ID: 25391010
[TBL] [Abstract][Full Text] [Related]
37. Real-time monitoring of the influenza vaccine field effectiveness.
Legrand J; Vergu E; Flahault A
Vaccine; 2006 Nov; 24(44-46):6605-11. PubMed ID: 16806607
[TBL] [Abstract][Full Text] [Related]
38. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
Arnoux S; Weinberger C; Gessner BD
Vaccine; 2007 Nov; 25(45):7720-31. PubMed ID: 17920168
[TBL] [Abstract][Full Text] [Related]
39. Increasing herd immunity with influenza revaccination.
Mooring EQ; Bansal S
Epidemiol Infect; 2016 Apr; 144(6):1267-77. PubMed ID: 26482721
[TBL] [Abstract][Full Text] [Related]
40. Vaccinating children against influenza increases variability in epidemic size.
Backer JA; van Boven M; van der Hoek W; Wallinga J
Epidemics; 2019 Mar; 26():95-103. PubMed ID: 30529023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
